DAVID P LUCI
CIK 1271123 · President and CEO · last filed 2026-04-22
DAVID P LUCI is a President and CEO who has filed 20 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for ACXP, was dated Apr 22, 2026. Across all open-market trades the lifetime net is +$175.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.75M
5
20
$175.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACXP | President and CEO | 1,112,541 | $1.57 | $1.75M | $150.0K | 9 | 2026-04-22 |
| Enveric Biosciences, Inc. (AMRHW) Delisted | Director | 2,430 | — | — | $0 | 1 | 2018-08-22 |
| PLx Pharma Inc. (PLXP) Delisted | Director | — | $0.09 | — | $0 | 1 | 2017-04-21 |
| PLx Pharma Inc. (DPRX) Delisted | President, CEO, Secretary | 1,836,909 | — | — | $25.0K | 3 | 2016-01-21 |
| BIOENVISION INC (BIVN) Delisted | EVP & General Counsel | 0 | — | — | $0 | 2 | 2007-07-12 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-22 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2025-01-08 | ACXP | Buy (P) | +49,261 | $50.0K | EDGAR |
| 2024-04-03 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2024-01-04 | ACXP | Exer (M) | +19,737 | $70.1K | EDGAR |
| 2023-02-24 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2022-07-29 | ACXP | Buy (P) | +19,737 | $75.0K | EDGAR |
| 2021-11-22 | ACXP | Buy (P) | +5,200 | $25.0K | EDGAR |
| 2021-07-06 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2018-08-22 | Enveric Biosciences, Inc. (AMRHW) Delisted | Grant (A) | — | $0 | EDGAR |